RxAdvance Corp Revenue and Competitors
Estimated Revenue & Valuation
- RxAdvance Corp's estimated annual revenue is currently $67.4M per year.
- RxAdvance Corp received $Undisclosed in venture funding in September 2016.
- RxAdvance Corp's estimated revenue per employee is $236,500
- RxAdvance Corp's total funding is $50M.
Employee Data
- RxAdvance Corp has 285 Employees.
- RxAdvance Corp grew their employee count by 43% last year.
RxAdvance Corp's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Strategy Officer & EVP Business Development | Reveal Email/Phone |
2 | Chief Data Architect | Reveal Email/Phone |
3 | SVP | Reveal Email/Phone |
4 | Controller | Reveal Email/Phone |
5 | SVP Operations & Innovation | Reveal Email/Phone |
6 | EVP | Reveal Email/Phone |
7 | SVP, Revenue Growth | Reveal Email/Phone |
8 | Director Product Management | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Senior Director, Medicare Operations | Reveal Email/Phone |
RxAdvance Corp Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $694.8M | 2256 | 7% | N/A | N/A |
#2 | $12.5M | 63 | 2% | N/A | N/A |
#3 | $68.2M | 282 | 9% | N/A | N/A |
#4 | $56.9M | 235 | 36% | N/A | N/A |
#5 | $2.4M | 18 | -31% | N/A | N/A |
#6 | $19.8M | 90 | -8% | N/A | N/A |
#7 | $20.7M | 94 | 7% | N/A | N/A |
#8 | $6.9M | 39 | 5% | N/A | N/A |
#9 | $0.7M | 6 | N/A | N/A | N/A |
#10 | $2.4M | 18 | -42% | N/A | N/A |
What Is RxAdvance Corp?
RxAdvance is a national full-service pharmacy benefit manager (PBM) leveraging Collaborative PBM Cloud to manage standard and specialty drug benefits with unmatched regulatory compliance and transparency. In addition, RxAdvance offers a global pharmacy risk partnership model standing shoulder-to-shoulder with plan sponsors. RxAdvance delivers integrated PBM services that reduce overall pharmacy costs and drug-impacted medical costs while improving patients quality of life. With Collaborative PBM Cloud, we administer comprehensive PBM services with operating costs 40% lower than the costs of any other PBM today, which leads to lower administrative fees, reduced drug unit costs, and increased rebate income to plan sponsors. With Intelligent DUR360 Gateway, we promote optimal utilization of drug benefits and reduce overall medical spend. By providing intelligence at the Point of Care and Point of Sale, and establishing a robust platform for member and plan sponsor engagement, we are setting the new standard in PBM service excellence. RxAdvance has created an innovative PBM paradigm that offers Pharmacy cost savings Optimal utilization of drug benefits by leveraging the Intelligent DUR360 Gateway Operational efficiency leading to lower administrative fees Promote untapped generics Control FWA Transform specialty management from a Buy & Bill model to a Value-Based & Outcome-Driven model Drug-impacted medical cost reduction and improved quality of life for patients Medication adherence management (MAM) Coverage gap prediction and prescription planning (CGP3) Reduced adverse drug events Integrated MTM with physician-led CMR Unmatched system-driven regulatory compliance minimizing personnel involvement Care stakeholder collaboration enhances communication between prescribers, pharmacists, patients, and plan sponsors Complete operational visibility and transparency to plan sponsors Unprecedented user configurability
keywords:Finance,Healthcare,Insurance,Pharmaceuticals$50M
Total Funding
285
Number of Employees
$67.4M
Revenue (est)
43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
RxAdvance Corp News
Tpg-Axon Management Lp increased its stake in Centene Corp Del ... IN HIS CURRENT ROLE AS CEO OF RXADVANCE (ADDS DROPPED ...
Somerset Trust Company increased its stake in Centene Corp Del Com ... 15/03/2018 – Ex-Apple chief says Centene, RxAdvance partnership ...
Centene says the rollout of its new relationship with the pharmacy benefit manager RxAdvance is proceeding as planned as the health insurer ...
Ravi Ika, President/CEO Among 100 Most Intriguing Entrepreneurs at 2017 Builders + Innovators Summit SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–October 18, 2017– Goldman Sachs (NYSE:GS) is recognizing RxAdvance President and CEO Ravi Ika as one of the 100 Most Intriguing Entrepreneurs of 2017 at its ...
SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–May 19, 2017– RxAdvance today announced that the International Association of Sheet Metal, Air, Rail and Transportation Workers (SMART), one of North America’s most dynamic and diverse unions with 216,000 members, has awarded its multi-year pharmacy benefit m ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $116.8M | 581 | -6% | N/A |
#2 | $448.6M | 1780 | N/A | N/A |
#3 | $3551.8M | 19106 | 4% | $154M |
RxAdvance Corp Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2014-03-04 | $Undisclosed | A1 | WellMed Medical Management, Inc | Article |
2016-09-01 | $Undisclosed | A | Uber | Article |